Press Coverage

See Beyond the Surface: How Cellvizio® Redefines Accuracy for Detecting and Treating Cancers

13 August 2025

This comprehensive feature written by Daryl C. Donatelli, MBA, President, U.S. & Head of Global Marketing, Mauna Kea Technologies explores the Cellvizio platform and details how the technology is transforming cancer detection and treatment across gastroenterology and pulmonology, offering physicians unprecedented accuracy in diagnosing pancreatic cysts, Barrett’s esophagus, and lung lesions. The article highlights how real-time cellular visualization enables earlier detection, reduces the need for repeat procedures, and helps physicians make more confident treatment decisions, ultimately leading to improved patient outcomes and reduced healthcare costs.

Read the full article here

Latest News

Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase 

Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase 

Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates 

Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates 

Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan

Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan

No results found.